Emisphere Technologies (EMIS) Stock Price, News & Analysis

Company Overview

Emisphere Technologies, trading under the symbol EMIS on the OTC market, is a drug‐delivery company specializing in proprietary technologies designed to enhance the oral absorption of therapeutic compounds. The company’s core innovation, the Eligen® carrier system, facilitates the transport of macromolecules—such as peptides, proteins and small molecules—across the intestinal lining, addressing a key barrier in orally administered therapies.

Over the years, Emisphere has established multiple collaborations and licensing agreements with leading pharmaceutical and biotechnology firms to apply its Eligen platform across a range of therapeutic areas. These partnerships have explored oral formulations for therapies including insulin, parathyroid hormone and vitamins, as well as small‐molecule drugs with limited bioavailability. The company’s research and development efforts have been supported by an extensive patent portfolio, protecting both composition of matter and formulation processes in major markets worldwide.

Headquartered in Roseland, New Jersey, Emisphere Technologies serves a global customer base through its network of strategic alliances in North America, Europe and Asia. The company’s leadership team combines expertise in pharmaceutical sciences, business development and regulatory affairs, driving efforts to advance clinical programs and expand the application of its oral delivery platforms. Emisphere’s focus remains on bridging the gap between laboratory‐scale innovation and commercial viability for oral formulations of traditionally injectable or poorly absorbed drugs.

Key Stats

• Today's Range: $7.81 to $7.81
• 50-Day Range: $7.81 to $7.81
• 52-Week Range: $4.06 to $9.16
• Volume: N/A
• Average Volume: N/A
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

EMIS Stock Analysis - Frequently Asked Questions

How have EMIS shares performed this year?

Emisphere Technologies' stock was trading at $7.81 at the beginning of the year. Since then, EMIS stock has increased by 0.0% and is now trading at $7.81.

How were Emisphere Technologies' earnings last quarter?

Emisphere Technologies Inc. (OTCMKTS:EMIS) announced its earnings results on Friday, May, 12th. The company reported $0.04 EPS for the quarter. The firm earned $0.22 million during the quarter.

How do I buy shares of Emisphere Technologies?

Shares of EMIS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Emisphere Technologies own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Emisphere Technologies investors own include Novo Nordisk A/S (NVO), Fulcrum Therapeutics (FULC), VIVUS (VVUS), Aldeyra Therapeutics (ALDX), Allena Pharmaceuticals (ALNA) and Capricor Therapeutics (CAPR).

Company Calendar

• Last Earnings: 5/12/2017
• Today: 9/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: MED - DRUGS
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:EMIS
• CIK: 805326
• Web: www.emisphere.com
• Phone: 973-532-8000
• Fax: 973-422-0125
• Employees: 6
• Year Founded: 1986

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A